FORM 10-K CONTANGO OIL & GAS COMPANY
FORM 10-K CONTANGO OIL & GAS COMPANY
FORM 10-K CONTANGO OIL & GAS COMPANY
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>CONTANGO</strong> <strong>OIL</strong> & <strong>GAS</strong> <strong>COMPANY</strong> AND SUBSIDIARIES<br />
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (continued)<br />
The Company accounts for employee stock-based compensation under the fair value method prescribed in<br />
SFAS 123. Prior to the adoption of SFAS 123(R), we presented all tax benefits resulting from the exercise of stock<br />
options as operating cash flows in the Consolidated Statement of Cash Flows. SFAS 123(R) requires that cash<br />
flows from the exercise of stock options resulting from tax benefits in excess of recognized cumulative<br />
compensation cost (excess tax benefits) be classified as financing cash flows. For the fiscal years ended June 30,<br />
2009, 2008 and 2007, approximately $0.3 million, $1.1 million and $0.2 million, respectively, of such excess tax<br />
benefits were classified as financing cash flows. See Note 2 – Summary of Significant Accounting Policies.<br />
All employee stock option grants are expensed over the stock options vesting period based on the fair value<br />
at the date the options are granted. The fair value of each option is estimated as of the date of grant using the Black-<br />
Scholes options-pricing model. During the fiscal year-ended June 30, 2009, 2008 and 2007, the Company recorded<br />
stock option expense of $1.1 million, $1.2 million and $1.3 million, respectively.<br />
As of June 30, 2009, we have approximately $1.5 million of total unrecognized compensation cost related<br />
to non-vested awards granted under our various share-based plans, which we expect to recognize over an average<br />
period of three years.<br />
The aggregate intrinsic values of the options exercised during fiscal years 2009, 2008 and 2007 were<br />
approximately $12.2 million, $1.9 million and $1.9 million, respectively.<br />
On November 11, 2008, the Company awarded a total of 3,088 shares of restricted stock under the 1999<br />
Plan to its board of directors. Of these 3,088 shares of restricted stock, 1,544 shares vest on the date of grant, and<br />
the remaining 1,544 shares vest one year thereafter. The fair value of restricted stock was approximately $144,000.<br />
On November 14, 2007, the Company awarded a total of 4,140 shares of restricted stock under the 1999 Plan to its<br />
board of directors. Of these 4,140 shares of restricted stock, 2,070 shares vest on the date of grant, and the<br />
remaining 2,070 shares vest one year thereafter. The fair value of restricted stock was approximately $180,000. On<br />
November 16, 2006, the Company’ awarded a total of 8,416 shares of restricted stock under the 1999 Plan to its<br />
board of directors. Of these 8,416 shares of restricted stock, 4,208 shares vest on the date of grant, and the<br />
remaining 4,208 shares vest one year thereafter. The fair value of restricted stock was approximately $144,000.<br />
For the year ended June 30, 2009, 2008 and 2007, the Company recognized $240,581, $252,435 and<br />
$153,979, respectively, in compensation expense relating to restricted stock awards. A summary of the Company’s<br />
restricted stock as of June 30, 2009, is as follows:<br />
Weighted<br />
Average<br />
Number of Fair Value<br />
Shares Per Share<br />
Nonvested balance at June 30, 2007……………………………… 15,375 $ 15.04<br />
Granted…………………………………………………………… 4,471 42.95<br />
Vested…………………………………………………………… (12,192) 20.80<br />
Forfeited…………………………………………………………… - -<br />
Nonvested balance at June 30, 2008……………………………… 7,654 $ 22.16<br />
Granted…………………………………………………………… 3,088 46.75<br />
Vested…………………………………………………………… (9,198) 26.29<br />
Forfeited…………………………………………………………… - -<br />
Nonvested balance at June 30, 2009……………………………… 1,544 $ 46.75<br />
DB2/2<strong>10</strong>43537.7 F-22